Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Apolipoprotein-B100 (apoB100) is the essential protein for the assembly and secretion of very low density lipoproteins (VLDL) from liver. The hepatoma HepG2 cell line has been the cell line of choice for the study of synthesis and secretion of human apoB-100. Despite the general use of HepG2 cells to study apoB100 metabolism, they secrete relatively dense, lipid-poor particles compared with VLDL secreted in vivo. Recently, Huh-7 cells were adopted as an alternative model to HepG2 cells, with the implicit assumption that Huh-7 cells were superior in some respects of lipoprotein metabolism, including VLDL secretion. In this study we addressed the hypothesis that the spectrum of apoB100 lipoprotein particles secreted by Huh-7 cells more closely resembles the native state in human liver. We find that Huh-7 cells resemble HepG2 cells in the effects of exogenous lipids, microsomal triglyceride transfer protein (MTP)-inhibition, and proteasome inhibitors of apoB100 secretion, recovery, and degradation. In contrast to HepG2 cells, however, MEK-ERK inhibition does not correct the defect in VLDL secretion. Huh-7 cells do not appear to offer any advantages over HepG2 cells as a general model of human apoB100-lipoprotein metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Fisher, E. A., & Ginsberg, H. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100068200 · Cited by 460
Self-citationFisher, E. A., Zhou, M., Mitchell, D. M., Wu, X., Omura, S., Wang, H., Goldberg, A. L., & Ginsberg, H. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20427 · Cited by 286
Self-citationPan, M., Cederbaum, A. I., Zhang, Y.-L., Ginsberg, H. N., Williams, K. J., & Fisher, E. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19197 · Cited by 279
Self-citationAn MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
Wetterau, J. R., Gregg, R. E., Harrity, T. W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.-H., George, R. J., Gordon, D. A., Jamil, H., et al. (1998) · Science · doi:10.1126/science.282.5389.751 · Cited by 267
Cotranslocational Degradation Protects the Stressed Endoplasmic Reticulum from Protein Overload
Oyadomari, S., Yun, C., Fisher, E. A., Kreglinger, N., Kreibich, G., Oyadomari, M., Harding, H. P., Goodman, A. G., Harant, H., Garrison, J. L., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.051 · Cited by 252
Self-citationOhsaki, Y., Cheng, J., Fujita, A., Tokumoto, T., & Fujimoto, T. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0659 · Cited by 205
Ubiquitin-Proteasome Pathway Mediates Intracellular Degradation of Apolipoprotein B
Yeung, S. J., Chen, S. H., & Chan, L. (1996) · Biochemistry · doi:10.1021/bi9618777 · Cited by 187
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism
Ginsberg, H. N., & Fisher, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800090-jlr200 · Cited by 172
Self-citationLipid droplets are arrested in the ER membrane by tight binding of lipidated apolipoprotein B-100
Ohsaki, Y., Cheng, J., Suzuki, M., Fujita, A., & Fujimoto, T. (2008) · Journal of Cell Science · doi:10.1242/jcs.025452 · Cited by 152
Cited by
Assembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
Virology and cell biology of the hepatitis C virus life cycle – An update
Dubuisson, J., & Cosset, F.-L. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.031 · Cited by 226
“However, this cell line lacks many features of hepatocytes [21].”
BackgroundFelmlee, D., Hafirassou, M., Lefevre, M., Baumert, T., & Schuster, C. (2013) · Viruses · doi:10.3390/v5051292 · Cited by 158
“This can be explained at least in part by the differences in the neutral lipid content of the LVP produced in cell culture vs. serum derived virions, since the cell type that sustains HCV replication, Huh7, secrete a majority of LDL-sized rather than VLDL-sized apoB bearing particles [110].”
BackgroundThi, V. L. D., Granier, C., Zeisel, M. B., Guérin, M., Mancip, J., Granio, O., Pénin, F., Lavillette, D., Bartenschlager, R. F. W., Baumert, T. F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365924 · Cited by 134
“in their apolipoprotein composition of viral subpopulations of different densities, as HCVcc-producing hepatocarcinoma cells are impaired at late steps of VLDL biogenesis and production (7, 87, 88), our study further extends these previous results (28) and underscores the notion that distinct capture molecules are use…”
ResultTai, M., Chen, P., Chen, P., Wu, M., Ho, C., & Yen, J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400366 · Cited by 124
Lindenbach, B. D. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_8 · Cited by 164
“The surface of VLDL and LDL particles are coated with a single copy of ApoB, a large (≈4500 amino acids), essential, amphipathic glycoprotein; VLDL and LDL particles also transiently associate with the exchangeable apolipoproteins ApoA5, ApoC1, ApoC2, ApoC3, ApoE.”
BackgroundInfluentialEslam, M., Mangia, A., Berg, T., Chan, H. L. Y., Irving, W. L., Dore, G. J., Abate, M. L., Bugianesi, E., Adams, L. A., Najim, M. A. M., et al. (2016) · Hepatology · doi:10.1002/hep.28475 · Cited by 122
“Very low-density lipoprotein (VLDL) secretion is nearly absent in Huh7 cells,((19)) and HepG2 cells secrete relatively dense, lipid-poor apolipoprotein B (apoB)-containing particles, unlike the buoyant VLDL particles secreted in vivo.((20)) The impact of TM6SF2 rs58542926 polymorphisms on serum lipoproteins in patient…”
BackgroundSantos, A. J. M., Nogueira, C., Ortega-Bellido, M., & Malhotra, V. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201603072 · Cited by 114
“Because Caco-2 cells mainly assemble and secrete chylomicrons, but large VLDLs are also ApoB-containing lipid particles reported to leave the ER in vesicles bigger than COP II-coated vesicles (100–120 nm compared with 60–90 nm; Siddiqi, 2008), we tested whether the absence of TAN GO1 or TALI also led to an intracellul…”
BackgroundInfluentialThe Mechanism of HCV Entry into Host Cells
Douam, F., Lavillette, D., & Cosset, F. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.003 · Cited by 137
Bassendine, M. F., Sheridan, D. A., Bridge, S. H., Felmlee, D. J., & Neely, R. D. G. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0356-2 · Cited by 121
Atypical Antipsychotics Alter Cholesterol and Fatty Acid Metabolism in Vitro
Canfrán-Duque, A., Casado, M. E., Pastor, Ó., Sánchez-Wandelmer, J., de la Peña, G., Lerma, M., Mariscal, P., Bracher, F., Lasunción, M. A., & Busto, R. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m026948 · Cited by 105
Hepatitis C virus and lipid droplets: finding a niche
Filipe, A. D. S., & McLauchlan, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.11.003 · Cited by 108
Stem cell-derived polarized hepatocytes
Thi, V. L. D., Wu, X., Belote, R. L., Andréo, U., Takacs, C. N., Fernandez, J., Vale-Silva, L. A., Prallet, S., Decker, C. C., Fu, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15337-2 · Cited by 112
Boyer, A., Dumans, A., Beaumont, É., Etienne, L., Roingeard, P., & Meunier, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.538256 · Cited by 109
Fisher, E. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.02.001 · Cited by 92
“It should be noted that Huh7 cells assemble very little apoB100 into VLDL particles [28], which limited the relevance of these interesting findings to more physiological settings.”
BackgroundSelf-citationGunn, P. J., Green, C. J., Pramfalk, C., & Hodson, L. (2017) · Physiological Reports · doi:10.14814/phy2.13532 · Cited by 73
“Although there are many reported similarities in the function of HepG2 and Huh7 cells, studies directly comparing the two cell lines are surprisingly sparse (Meex et al. 2011; Green et al. 2015b).”
BackgroundResultInfluentialCai, H., Jiang, Z., Yang, X., Lin, J., Cai, Q., & Li, X. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0271 · Cited by 71
“Cells were maintained at 37°C in a humidified atmosphere containing 5% CO2 [15].”
MethodGrubb, S. R., Guo, L., Fisher, E. A. A., & Brodsky, J. L. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-08-0704 · Cited by 76
“The proteasome dependence of ApoB100 degradation and secretion was performed as described (Meex et al., 2011) with either DMSO or the proteasomal inhibitor MG132 (Z-Leu-Leu-Leu-al; Sigma, St.”
MethodSelf-citationGenetic and epigenetic mechanisms of NASH
Eslam, M., & George, J. (2015) · Hepatology International · doi:10.1007/s12072-015-9689-y · Cited by 72
“VLDL secretion is nearly absent in Huh7 cells [64] and HepG2 cells secrete relatively dense, lipid poor apolipoprotein B (apoB)-containing particles, unlike the buoyant VLDL particles that are secreted in vivo [65].”
BackgroundSamanez, C. H., Caron, S., Briand, O., Dehondt, H., Duplan, I., Kuipers, F., Hennuyer, N., Clavey, V., & Staels, B. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.683442 · Cited by 66
“Huh-7 do not exhibit better properties as compared to HepG2 model to study lipoprotein metabolism, particularly in the regulation of VLDL secretion (Meex et al., 2011).”
BackgroundA specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth
Lu, M. H., Hu, X., Li, Q., Xiong, Y., Hu, G., Xu, J., Zhao, X., Wei, X.-X., Chang, C. C. Y., Liu, Y., et al. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt039 · Cited by 68
“According to previous reports that VLDL particles secreted by Huh7 and HepG2 cells were predominant in the LDL range (Meex et al., 2011; Higashi et al., 2002), LDL-sized particles separated”
BackgroundResultHCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit
Vièyres, G., & Pietschmann, T. (2019) · Cells · doi:10.3390/cells8030233 · Cited by 70
“Along the same line, both the Huh-7 and HepG2 cell lines only produce poorly lipidated ApoB-containing lipoproteins [10,115,118].”
BackgroundCurrent limitations and future opportunities for prediction of DILI from in vitro
Funk, C., & Roth, A. B. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1874-9 · Cited by 67
“Traditionally, in vitro systems used to address DILI consisted of transformed and immortalized hepatic cell lines such as HepG2 or Huh7 which have the technical advantage of ease of use, propagatability, decent level of stability and bearing some aspects of hepatocyte-like features such as production of albumin (Davea…”
BackgroundHCV and the hepatic lipid pathway as a potential treatment target
Bassendine, M. F., Sheridan, D. A., Felmlee, D. J., Bridge, S. H., Toms, G. L., & Neely, R. D. G. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.004 · Cited by 77
“However, the hepatoma cell lines used secrete relatively dense lipid-poor apoB-containing particles, unlike the buoyant VLDL particles secreted in vivo by the human liver [54].”
Eric, F., Elizabeth, L., & Roger, S. (2014) · The Journal of Biomedical Research · doi:10.7555/jbr.28.20140019 · Cited by 61
“ERAD of apoB is not unique to the HepG2 cell line and can also be demonstrated in the rat hepatoma McA-RH7777 [111] .”
BackgroundInfluentialSteenbergen, R. D. M., Joyce, M., Thomas, B., Jones, D. M., Law, J. L., Russell, R. S., Houghton, M., & Tyrrell, D. L. (2013) · Hepatology · doi:10.1002/hep.26566 · Cited by 61
Entry and replication of recombinant hepatitis C viruses in cell culture
Vièyres, G., & Pietschmann, T. (2012) · Methods · doi:10.1016/j.ymeth.2012.09.005 · Cited by 69
Ehrhardt, N., Doche, M. E., Chen, S., Mao, H. Z., Walsh, M. T., Bedoya, C., Guindi, M., Xiong, W., Ignatius Irudayam, J., Iqbal, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx159 · Cited by 60
“As limited TG availability within the ER is one of the key mechanisms triggering APOB degradation, we attempted to rescue the secretion defect in Tm6sf2-overexpressing cells by oleic acid (OA) supplementation, a treatment known to promote APOB lipidation and secretion (21).”
BackgroundShi, J., Wang, X., Lyu, L., Jiang, H., & Zhu, H. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.03.003 · Cited by 66
“Consequently, these cell lines have been widely used as in vitro models for various studies, such as drug metabolism and toxicity [3–5], lipid metabolism and obesity [6, 7], carcinogenesis and anticancer research [8–10], and virology [11, 12].”
MethodScholtès, C., Ramière, C., Rainteau, D. P., Perrin‐Cocon, L., Wolf, C., Humbert, L., Carreras, M., Guironnet‐Paquet, A., Zoulim, F., Bartenschlager, R. F. W., et al. (2012) · Hepatology · doi:10.1002/hep.25628 · Cited by 57
“Poor lipidation of apoB in Huh7 compared with other cell lines might explain these differences.(21) ApoB-competent cellular models thus produce subviral particles that are recombinant E1E2-containing lipoproteins, associated or not with apoB, depending on the cell.”
BackgroundLipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry
Maillard, P., Walic, M., Meuleman, P., Roohvand, F., Huby, T., Goff, W. L., Leroux-Roels, G. G., Pécheur, E., & Budkowska, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026637 · Cited by 58
“Deficiencies in the transfer of lipids to the nascent ApoB in hepatoma cell lines leads to degradation of most of the Apo B produced [45].”
BackgroundRegression of Atherosclerosis: The Journey From the Liver to the Plaque and Back
Fisher, E. A. A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.301926 · Cited by 60
Self-citationVercauteren, K., Eede, N. V. D., Mesalam, A. A., Belouzard, S., Catanese, M. T., Bankwitz, D., Wong‐Staal, F., Cortese, R., Dubuisson, J., Rice, C. M., et al. (2014) · Hepatology · doi:10.1002/hep.27196 · Cited by 54
“For the in vitro experiments we used HCVcc that were produced in hepatoma cells, which are known to have impaired VLDL biogenesis.(28,29) For the in vivo experiments the same HCVcc was used to initially infect the mice but new viral particles are rapidly produced, this time by fully functional primary hepatocytes.”
MethodUp-Regulation of the ATP-Binding Cassette Transporter A1 Inhibits Hepatitis C Virus Infection
Bocchetta, S., Maillard, P., Yamamoto, M., Gondeau, C., Douam, F., Lebreton, S., Lagaye, S., Pol, S., Helle, F., Plengpanich, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092140 · Cited by 55
“limitations, especially concerning lipoprotein metabolism [72].”
Zhou, F. Y., Wu, X., Pinos, I., Abraham, B. M., Barrett, T. J., Lintig, J. V., Fisher, E. A. A., & Amengual, J. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120001066 · Cited by 58
Self-citationChen, H.-C., Chen, P.-Y., Wu, M.-J., Tai, M.-H., & Yen, J.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162414 · Cited by 45
“In the present study, we aim to investigate the hypocholesterolemic effects of tanshinone IIA and underlyingmechanisms in HepG2 cells, which are generally used as a model to study the human LDL-C metabolism [26].”
BackgroundAutophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100
Amengual, J., Guo, L., Strong, A., Madrigal‐Matute, J., Wang, H., Kaushik, S., Brodsky, J. L., Rader, D. J., Cuervo, A. M., & Fisher, E. A. A. (2018) · Circulation Research · doi:10.1161/circresaha.117.311240 · Cited by 53
Self-citationPositively charged, surfactant-free gold nanoparticles for nucleic acid delivery
Guo, J., Armstrong, M. J., O’Driscoll, C. M., Holmes, J. D., & Rahme, K. (2015) · RSC Advances · doi:10.1039/c4ra16294c · Cited by 47
Lin, H., Wang, L., Liu, Z., Long, K., Kong, M., Ye, D., Chen, X., Wang, K., Wu, K. K., Fan, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202200742 · Cited by 57
Jammart, B., Michelet, M., Pécheur, E., Parent, R., Bartosch, B., Zoulim, F., & Durantel, D. (2013) · Journal of Virology · doi:10.1128/jvi.01405-12 · Cited by 42
“Cells at confluence were treated for 3 days with 2% dimethyl sulfoxide (DMSO) and then incubated for another 24 h in a 5% CO2-normoxia incubator at 37°C with fresh medium deprived of serum and containing either 10% (vol/vol) BSA-coupled oleic acid (10 mg/ml BSA and 300 M OA final concentrations) and 1 M U0126 (20 mM s…”
BackgroundInfluentialPerrin-Cocon, L., Vidalain, P.-O., Jacquemin, C., Aublin-Gex, A., Olmstead, K., Panthu, B., Rautureau, G. J. P., André, P., Nyczka, P., Hütt, M.-T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01749-3 · Cited by 42
Nissilä, E., Ohsaki, Y., Weber‐Boyvat, M., Perttilä, J., Ikonen, E., & Olkkonen, V. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.004 · Cited by 51
Hepatitis C Virus Uses Host Lipids to Its Own Advantage
Sidorkiewicz, M. (2021) · Metabolites · doi:10.3390/metabo11050273 · Cited by 46
“Huh7 cells secrete more LDL-sized than VLDL-sized particles [54].”
BackgroundControl of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33
Allen, R. M., Marquart, T. J., Jesse, J. J., & Baldán, Á. (2014) · Circulation Research · doi:10.1161/circresaha.115.303100 · Cited by 38
“Importantly, under these conditions, APOB secretion is typically inefficient.(21) Our data show that MTTP protein levels did not change in cells overexpressing NSF, compared with control cells (Figure 6A), despite the significant increase in mRNA levels (Online Figure IVB).”
Green, C., Pramfalk, C., Morten, K., & Hodson, L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00192.2014 · Cited by 40
Green, C. J., Parry, S. A., Gunn, P. J., Ceresa, C. D. L., Rosqvist, F., Piché, M.-E., & Hodson, L. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0038 · Cited by 37
Gondar, V., Molina‐Jiménez, F., Hishiki, T., García-Buey, L., Koutsoudakis, G., Shimotohno, K., Benedicto, I., & Majano, P. L. (2015) · Journal of Virology · doi:10.1128/jvi.00577-15 · Cited by 39
“VLDL particles contain apolipoproteins B (ApoB) and E (ApoE), which are required for viral assembly and/or infectivity.”
BackgroundInfluentialNourbakhsh, M., Douglas, D. N., Pu, C. H., Lewis, J. T., Kawahara, T., Lisboa, L. F., Wei, E., Asthana, S., Quiroga, A. D., Law, L. M. J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.022 · Cited by 35
Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes
Wanninger, J., Neumeier, M., Bauer, S., Weiß, T. S., Eisinger, K., Walter, R. B., Dorn, C., Hellerbrand, C., Schäffler, A., & Buechler, C. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.003 · Cited by 36
“To prove that BAMBI antagonizes TGFb1 activity in hepatoma cells which are commonly used as a model to study hepatocyte function [30,31] BAMBI protein was transiently overexpressed in HepG2 cells, and cells were subsequently treated with increasing amounts of TGFb1 for 48 h.”
Wang, T., Li, X., Liao, G., Wang, Z., Han, X., Gu, J., Mu, X., Qiu, J., & Qian, Y. (2024) · Foods · doi:10.3390/foods13010163 · Cited by 39
Calattini, S., Fusil, F., Mancip, J., Thi, V. L. D., Granier, C., Gadot, N., Scoazec, J., Zeisel, M. B., Baumert, T. F., Lavillette, D., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662999 · Cited by 37
“However, most of these cell lines have impaired production of VLDL because they express pre-VLDLs that are not fully lipidated and that do not fuse with apoE-containing luminal lipid droplets (30).”
BackgroundLou, B., Dong, J., Li, Y., Ding, T., Bi, T., Li, Y., Deng, X., Ye, D., & Jiang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102641 · Cited by 33
“Huh-7 (a human hepatoma cell line) cells [29] were cultured in high-glucose DMEM with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin at 37uC, 5% CO2.”
MethodInfluentialZhang, T., Shi, H., Liu, N., Tian, J., Zhao, X., Steer, C. J., Han, Q., & Song, G. (2020) · Theranostics · doi:10.7150/thno.39578 · Cited by 33
“CP-10447, an inhibitor of MTP, can inhibit ApoB secretion from HepG2 cells [38, 39], allowing us to study the role of miR-378a-3p in modulating degradation of ApoB.”
BackgroundPrenylcysteine oxidase 1, an emerging player in atherosclerosis
Banfi, C., Baetta, R., Barbieri, S. S., Brioschi, M., Guarino, A., Ghilardi, S., Sandrini, L., Eligini, S., Polvani, G., Bergman, O., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02630-z · Cited by 35
HCV Assembly and Egress via Modifications in Host Lipid Metabolic Systems
Shimotohno, K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036814 · Cited by 34
The monoacylglycerol acyltransferase pathway contributes to triacylglycerol synthesis in HepG2 cells
McFie, P. J., Patel, A., & Stone, S. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-08946-y · Cited by 28
Human serum activates CIDEB-mediated lipid droplet enlargement in hepatoma cells
Singaravelu, R., Lyn, R. K., Srinivasan, P., Delcorde, J., Steenbergen, R. H., Tyrrell, D. L., & Pezacki, J. P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.080 · Cited by 26
Pramfalk, C., Larsson, L., Härdfeldt, J., Eriksson, M., & Parini, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.10.008 · Cited by 28
Schöbel, A., Rösch, K., & Herker, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-22243-7 · Cited by 26
The development of tertiary amine cationic lipids for safe and efficient siRNA delivery
Lin, Z., Bao, M., Yu, Z., Xue, L., Ju, C., & Zhang, C. (2019) · Biomaterials Science · doi:10.1039/c9bm00494g · Cited by 25
Gorji‐Bahri, G., Moradtabrizi, N., Vakhshiteh, F., & Hashemi, A. (2021) · Cell Biology International · doi:10.1002/cbin.11556 · Cited by 27
Perilipin-2 is critical for efficient lipoprotein and hepatitis C virus particle production
Lassen, S., Grüttner, C., Nguyen-Dinh, V., & Herker, E. (2018) · Journal of Cell Science · doi:10.1242/jcs.217042 · Cited by 23
“Huh7-derived cell lines display a defect in VLDLmetabolism; they produce VLDLs that are less lipidated than normal VLDLs and secrete ApoB and ApoE independently (Meex et al., 2011; Schöbel et al., 2018).”
BackgroundPNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells
Taxiarchis, A., Mahdessian, H., Silveira, A. M. V., Fisher, R. M., & Hooft, F. M. V. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m090928 · Cited by 24
“(26), although it is generally thought that the overall mechanism of triglyceride metabolism and TRL secretion is retained in these cells (reviewed in Ref.”
BackgroundBurks, K. H., Xie, Y., Gildea, M. A., Jung, I., Mukherjee, S. K., Lee, P. C., Pudupakkam, U., Wagoner, R., Patel, V., Santana, K., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100500 · Cited by 20
Self-citationDGAT2 stability is increased in response to DGAT1 inhibition in gene edited HepG2 cells
McFie, P. J., Chumala, P., Katselis, G. S., & Stone, S. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158991 · Cited by 20
Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet
Imai, N., Suzuki, M., Hayashi, K., Ishigami, M., Hirooka, Y., Abe, T., Shioi, G., Goto, H., & Fujimoto, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127114 · Cited by 20
“A similar decrease in ApoB secretion was observed in HepG2, a hepatocellular cell line that retains the ability to secrete ApoB [25], when UBXD8 was knocked down by siRNA transfection (Fig 7B).”
BackgroundInvolvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion
Tsuchiya, H., & Oura, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051450 · Cited by 16
“Both HuH7 and HepG2 cell lines are derived from highly differentiated human HCC and are functionally similar in many aspects [17].”
BackgroundGeneration of hepatoma cell lines deficient in microsomal triglyceride transfer protein
Anaganti, N., Chattopadhyay, A., Poirier, J. T., & Hussain, M. M. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100257 · Cited by 15
Wang, H., Nikain, C. A., Fortounas, K. I., Amengual, J., Tufanlı, Ö., Forest, M. L., Yu, Y., Wang, M. C., Watts, R., Lehner, R. S., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102048 · Cited by 21
Self-citationMiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver
Tian, F., Ying, H., Wang, Y.-Y., Cheng, B.-N., & Chen, J. (2020) · Yonsei Medical Journal · doi:10.3349/ymj.2020.61.9.780 · Cited by 15
“HepG2 cells, human liver cells, were cultured in DMEM medium (Gibco) containing 10% fetal bovine serum (FBS) and 233.6 mg/mL of glutamine at 37°C, 5% CO2.”
InfluentialLu, Y., Wu, X., Li, W. C., Zhuo, C., Xu, Z., Tan, C. P., Ma, R., Wang, J., & Pu, J. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820983029 · Cited by 15
“Besides, Hep3B and Huh-7 cell lines were utilized to assess the drug metabolism and toxicity of the human liver despite being proposed as an in vitro model for human hepatocellular carcinoma cells.(34,35) On the other hand, the role of SLC6A8 in human hepatocellular carcinoma cells was examined following the SLC6A8 ge…”
MethodSun, X., Liu, Y., Zhou, S., Wang, L., Wei, J., Hua, R., Shen, Z., & Yoshida, S. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00911-6 · Cited by 15
ERK1/2 regulates hepatocyte Trib1 in response to mitochondrial dysfunction
Soubeyrand, S., Naing, T., Martinuk, A., & McPherson, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.10.001 · Cited by 17
Eberhart, T., Eigner, K., Filik, Y., Fruhwürth, S., Stangl, H., & Röhrl, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.110 · Cited by 14
Olivieri, O., Speziali, G., Castagna, A., Pattini, P., Udali, S., Pizzolo, F., Liesinger, L., Gindlhuber, J., Tomin, T., Schittmayer, M., et al. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa202 · Cited by 15
Liu, N., Tian, J., Steer, C. J., Han, Q., & Song, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000672 · Cited by 13
“[33] To determine the effects of miR-206 on ApoB100 production and secretion, we transfected HepG2 cells with scramble or miR-206 mimic.”
TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway
Yang, N. V., Chao, J. Y., Garton, K. A., Tran, T., King, S. M., Orr, J., Oei, J. H., Crawford, A. P., Kang, M., Zalpuri, R., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102056 · Cited by 12
“…promotes the classic bile acid synthesis pathway, while inhibiting the alternative pathway via STAR Since oxysterols serve as precursors of bile acid synthesis, we tested whether TOMM40 KD-induced increases in oxysterol levels resulted in increased total bile acid secretion in HepG2 cells [27].”
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems
Kiss, I., Neuwert, N., Oberle, R., Hengstschläger, M., Osmanagic-Myers, S., & Stangl, H. (2025) · Biomolecules · doi:10.3390/biom15070956 · Cited by 11
“In addition, hepatoma cell lines were employed to gain insight into ApoB assembly and secretion [131] and the regulation of the LDLR by PCSK9 [132].”
Hsp40s play distinct roles during the initial stages of apolipoprotein B biogenesis
Kumari, D., Fisher, E. A., & Brodsky, J. L. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-09-0436 · Cited by 11
“The DNAJA1 molecular chaperone associates with and facilitates the degradation of ApoB100 in mammalian cells Among the model systems used to study ApoB biology, McArdle cells, a rat hepatoma cell line, are ideal because they endogenously express and secrete lipidated ApoB100 that resembles VLDL (Meex et al., 2011).”
BackgroundInfluentialSelf-citationKausar, H., Gull, S., Ijaz, B., Ahmad, W., Sarwar, M. T., Iqbal, Z., Nawaz, Z., Riazuddin, S. A., & Hassan, S. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-186 · Cited by 13
Zheng, N., Wang, T., Wei, A., Chen, W., Zhao, C., Li, H., & Wang, L. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3821 · Cited by 11
Andréo, U., de Jong, Y. P., Scull, M. A., Xiao, J., Vercauteren, K., Quirk, C., Mommersteeg, M. C., Bergaya, S., Menon, A. A., Fisher, E. A. A., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.07.002 · Cited by 11
“Although the development of a cell culture system to study HCV in vitro has enabled the discovery of essential host factors for HCV assembly, such as apoE, none of the cell lines that are used to produce HCV particles fully recapitulate VLDL assembly.(21) It remains unclear if HCV assembly and particle composition tru…”
BackgroundSelf-citationLipoprotein Receptors and Lipid Enzymes in Hepatitis C Virus Entry and Early Steps of Infection
Pécheur, E. (2012) · Scientifica · doi:10.6064/2012/709853 · Cited by 12
Nishi, H., & Fisher, E. A. (2015) · Circulation Research · doi:10.1161/circresaha.115.305467 · Cited by 7
Self-citationPhokrai, P., Poolsri, W., Suwankulanan, S., Phakdeeto, N., Kaewkong, W., Pekthong, D., Richert, L., & Srisawang, P. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12435 · Cited by 9
Chronic Alcohol Exposure of Cells Using Controlled Alcohol-Releasing Capillaries
Kim, W., Jeong, H., Kim, S. C., Choi, C., & Lee, K. (2021) · Cells · doi:10.3390/cells10051120 · Cited by 9
Röhrl, C., Steinbauer, S., Bauer, R., Roitinger, E., Otteneder, K., Wallner, M., Neuhauser, C., Schwarzinger, B., Schwarzinger, C., Stangl, H., et al. (2021) · Food & Function · doi:10.1039/d1fo01169c · Cited by 14
Visootsat, A., Payungporn, S., & T‐Thienprasert, N. P. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3928-0 · Cited by 9
Takacs, C. N., Andreo, U., Belote, R. L., Pulupa, J., Scull, M. A., Gleason, C. E., Rice, C. M., & Simon, S. M. (2017) · Traffic · doi:10.1111/tra.12467 · Cited by 10
Larsen, L. E., Smith, M. A., Abbey, D., Korn, A., Reeskamp, L. F., Hand, N. J., & Holleboom, A. G. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.03.014 · Cited by 9
Gunn, P. J., Pramfalk, C., Millar, V., Cornfield, T., Hutchinson, M., Johnson, E. M., Nagarajan, S. R., Troncoso‐Rey, P., Mithen, R. F., Pinnick, K. E., et al. (2020) · Physiological Reports · doi:10.14814/phy2.14482 · Cited by 12
Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
Schaefer, E. A. K., Meixiong, J., Mark, C., Deik, A., Motola, D., Fusco, D. N., Yang, A., Brisac, C., Salloum, S., Lin, W., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9954 · Cited by 8
Kuboyama‐Sasaki, A., Takahashi, Y., Chen, X., Hiro, K., Kobayashi, T., Ohdan, H., Shimizu, M., Yamauchi, Y., Kiyono, H., & Sato, R. (2023) · Biotechnology Journal · doi:10.1002/biot.202300365 · Cited by 7
“Consistent with a previous report, [30] HepG2 cells rarely secreted apoB-100 in the VLDL fraction (0.950–1.006 g mL -1 ), accounting for only 1.9% of the total apoB-100 proteins (Figure 5B).”
BackgroundResultInfluentialGeneration of new hepatocyte-like in vitro models better resembling human lipid metabolism
Pramfalk, C., Jakobsson, T., Verzijl, C. R. C., Minniti, M. E., Obensa, C., Ripamonti, F., Olin, M., Pedrelli, M., Eriksson, M., & Parini, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158659 · Cited by 8
Meurs, A., Ndoj, K., van den Berg, M., Marinković, G., Tantucci, M., Veenendaal, T., Kuivenhoven, J. A., Klumperman, J., & Zelcer, N. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae121 · Cited by 6
“27,28 With the exception of VLDL-sized particles that are produced in rat McArdle cells, 33,34 these particles do not fully mimic VLDL in humans.”
BackgroundCheng, V., Reddam, A., Bhatia, A., Hur, M., Kirkwood, J. S., & Volz, D. C. (2021) · Current Research in Toxicology · doi:10.1016/j.crtox.2021.03.003 · Cited by 6
The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease
Kotlyarova, A., Iskrina, A., & Kotlyarov, S. (2026) · International journal of molecular sciences · doi:10.3390/ijms27083399 · Cited by 10
Human hepatoma Huh-7 cell culture models deficient in apolipoprotein B secretion
Valmiki, S., Rosário, S., Mooring, A., Prakashmurthy, C., Schlamp, F., Prakash, B., Chattopadhyay, A., Ansari, A., Alemán, J. O., Pamir, N., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100867 · Cited by 5
“The human hepatoma Huh-7 cells express MTP and apoB100 and support the assembly and secretion of apoB100-containing lipoproteins (14, 15, 30).”
da Silveira, M. B., Pansa, C. C., Malaspina, O., & Moraes, K. C. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06364-3 · Cited by 5
Cheng, V., & Volz, D. C. (2022) · Current Research in Toxicology · doi:10.1016/j.crtox.2022.100079 · Cited by 6
“For this study, we relied on human hepatocellular carcinoma (HepG2) cells as a model since these liver cells express basal levels of PPARγ and have previously been used to study lipoprotein metabolism (Meex et al., 2011) and regulation of drug metabolizing enzymes (Wilkening et al.”
Method
Metadata
- Authors
- Meex, S. J. R., Andreo, U., Sparks, J. D., & Fisher, E. A.
- Affiliations
- NYU Langone Health (US)
- University of Rochester Medicine (US)
- New York University (US)
- Corresponding author
- Fisher, Edward A.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 52
- Issue
- 1
- Pages
- 152-158
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC2999930
- OpenAlex
- W1980467489
- Cited by
- 129
- References
- 21
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 12 · 2020: 11 · 2019: 8 · 2018: 8 · 2017: 4 · 2016: 9 · 2015: 12 · 2014: 14 · 2013: 8 · 2012: 11
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3577 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Heart, Lung, and Blood Institute (HL 58541, R01HL058541)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- apolipoprotein B-100, VLDL secretion, Huh7 cells, HepG2 cells, cell line comparison, microsomal triglyceride transfer protein, MEK/ERK signaling, proteasome inhibitors, hepatocyte models, lipoprotein assembly
- MeSH terms
- Cell Line, Humans, Lipoproteins, VLDL, Models, Biological, Extracellular Signal-Regulated MAP Kinases, Apolipoprotein B-100, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.